America’s Infant Formula Rules Face Major Overhaul As FDA Reveals New Contaminant Testing Results

American parents could soon see major changes to the nutritional standards governing the formula they feed their babies. Nearly three decades after the last comprehensive review, the Trump administration has announced plans to modernize federal infant formula requirements, raising questions about what goes into products consumed by millions of babies across the country. The announcement also comes with new FDA testing results examining chemical contaminants in infant formula, giving families fresh information about the products they rely on.

Health and Human Services Secretary Robert F. Kennedy Jr. announced the two actions on October 29, 2026, as part of President Donald Trump’s Operation Stork Speed and Make America Healthy Again initiative. The FDA is proposing updated requirements for several essential nutrients while releasing data showing that most tested formula samples contained low or non-detectable levels of chemical contaminants. Although the proposed regulations are still subject to public review, the announcement marks a significant development in how infant formula is monitored and regulated in the United States.

FDA Proposes First Major Infant Formula Update Since 1998

The US Food and Drug Administration has announced its first comprehensive review of infant formula nutrient requirements since 1998. The agency says the proposed changes are intended to ensure that nutritional standards reflect available scientific evidence supporting healthy infant growth and development. The review covers the 30 nutrients currently required in infant formula marketed across the United States, making this a substantial examination of existing federal requirements.

The announcement forms part of the Trump administration’s broader effort to change how infant nutrition and food safety are addressed. Speaking at Amanda the Panda Children Center in Des Moines, Iowa, HHS Secretary Robert F. Kennedy Jr. explained the administration’s position on the proposed changes. “Parents deserve confidence in every bottle they feed their baby,” Kennedy said. He added that the administration intends to strengthen nutritional requirements, test formula for contaminants, and make the results available directly to parents.

The FDA’s announcement contains two separate actions. The first is a proposed rule that would update specific nutritional requirements, while the second involves releasing new chemical contaminant testing results. Together, these measures are intended to improve regulatory oversight and provide families with more information about infant formula products. However, the proposed nutritional changes must still go through the regulatory process before becoming final requirements.

Four Nutrients Could Face Updated Requirements

The first phase of the FDA’s review focuses on iodine, manganese, vitamin A, and vitamin D. These four nutrients are already part of the existing requirements for infant formula, but the agency wants to update their standards using available scientific evidence. The proposal is intended to ensure that the required amounts reflect current understanding of infant nutritional needs during early development.

The agency also plans to reaffirm existing requirements for chloride, potassium, selenium, and sodium. These nutrients are part of the current nutritional framework, and the FDA’s proposal would maintain their existing requirements. Additionally, the agency wants to change the units of measurement used for two nutrients. The announcement does not identify those two nutrients in the supplied information.

Another significant part of the proposal involves ingredients that manufacturers commonly add to infant formula even though they are not currently mandatory under federal requirements. The FDA is requesting public feedback on whether certain ingredients should receive additional consideration. These include arachidonic acid (ARA), docosahexaenoic acid (DHA), and L-carnitine, which the agency identifies as having evidence supporting their contribution to neurodevelopmental health during infancy.

DHA And ARA Could Receive Greater Regulatory Attention

DHA and ARA are fatty acids associated with infant development and are already commonly included in some infant formula products. DHA, short for docosahexaenoic acid, is an omega-3 fatty acid, while ARA, or arachidonic acid, is an omega-6 fatty acid. Their presence in the FDA’s announcement suggests that the agency is examining whether ingredients currently added by manufacturers should receive greater attention within federal nutritional standards.

L-carnitine is another ingredient included in the agency’s request for public input. The FDA has identified evidence supporting its contribution to neurodevelopmental health during infancy. However, the agency has not announced that any of these ingredients will automatically become mandatory. Their inclusion in the proposal reflects an invitation for feedback as the broader nutritional review continues.

The distinction is important for parents and manufacturers because the current proposal does not immediately change the ingredients that companies must include in their products. The FDA is gathering information before deciding whether additional requirements are justified. Any eventual changes will depend on the evidence considered during the rulemaking process and the agency’s final decisions.

Why The FDA Is Reviewing Formula Standards Now

Infant formula provides essential nutrition for babies who are not breastfed or who need additional feeding support. Because it can serve as a major source of nourishment during early development, its nutritional composition is subject to federal requirements. The FDA currently regulates requirements covering 30 nutrients in infant formula, but those standards have not undergone a comprehensive review since 1998.

The agency says its latest effort is intended to bring those requirements in line with available scientific evidence. FDA Acting Commissioner Kyle Diamantas described the proposed changes as an effort to modernize nutritional standards for American babies. “Under President Trump’s leadership, we are modernizing our nutritional requirements for infant formula for the first time in nearly three decades,” Diamantas said.

The review is being conducted in three phases, allowing the FDA to advance individual proposals and receive public feedback as each stage is completed. The first proposal addresses selected existing nutrient requirements, while later phases will examine the remaining nutrients, possible additional nutrient requirements, and carbohydrate sources. Once the review is complete, the agency intends to combine the final changes into one comprehensive rule.

FDA Releases New Infant Formula Contaminant Testing Results

Alongside the proposed nutritional changes, the FDA has released new chemical contaminant testing data covering infant formula samples. The headline finding is reassuring: most samples tested had low or non-detectable levels of chemical contaminants. The agency also said these findings were consistent with results released earlier in 2026, providing another update on its ongoing monitoring of infant formula products.

However, low levels and non-detectable levels do not mean exactly the same thing. A non-detectable result means a substance was not identified using the testing method, while a low result indicates that some amount was detected. The FDA’s announcement does not claim that every sample was completely free of chemical contaminants, so the findings should not be interpreted as a guarantee that all products contain zero contaminants.

To make the information easier for families to access, the agency has launched a new Infant Formula Testing Webpage and an Infant Formula Chemical Contaminants Dashboard. These resources are designed to help parents explore the available testing information. The FDA also says it is continuing work under its Closer to Zero initiative, which aims to establish action levels for certain chemical contaminants in infant formula.

What The Proposed Changes Could Mean For Manufacturers

If the proposed rule is finalized, infant formula manufacturers could face updated requirements covering the nutrients identified in the first phase. Companies may need to review their existing formulations and ensure their products comply with any new standards eventually adopted by the FDA. The agency’s broader review could also lead to additional requirements involving ingredients that are currently optional.

Manufacturers and other interested parties will have an opportunity to provide feedback before the agency reaches its final decisions. The FDA is inviting comments from parents, caregivers, doctors, clinicians, researchers, industry representatives, and members of the public. Their submissions will become part of the process used to evaluate the proposed changes.

The eventual outcome will depend on the evidence considered and the decisions made during the rulemaking process. For now, the announcement represents the beginning of a regulatory review rather than an immediate change to the formula products available in stores. Existing requirements remain in place while the agency considers public feedback and develops its comprehensive final rule.

Parents Have Until February 2027 To Submit Comments

The FDA has opened a public comment period for its proposed infant formula nutrient requirements, with submissions accepted until February 26, 2027. Parents and caregivers who want to share their concerns or opinions about infant nutrition can participate in the process. The agency is also encouraging healthcare professionals and members of the scientific community to provide relevant feedback.

Electronic comments can be submitted through Regulations.gov using docket number FDA-2026-56789. Those who prefer written submissions can send them to the Dockets Management Staff at the Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Written comments should identify the docket number and the proposal titled “Infant Formula Nutrient Requirements.”

The public comment process gives families an opportunity to contribute to a review that could influence nutritional standards for years to come. The FDA will consider the feedback as it works through the remaining phases of its review. Any final changes will be consolidated into a comprehensive rule rather than taking effect immediately following the announcement.

Current Infant Formula Requirements Remain In Place

Despite the announcement, parents should understand that the proposed changes have not yet become final regulations. The FDA is still reviewing the available evidence and gathering public feedback before deciding which changes should become part of federal requirements. The latest announcement also does not instruct parents to stop using their current formula or switch to a different brand.

Families with questions about their baby’s nutritional needs should continue discussing feeding decisions with their healthcare providers. The new testing resources offer another way to examine information about chemical contaminants, while the proposed rule provides an opportunity for the public to participate in the regulatory process.

After nearly 30 years without a comprehensive review, infant formula standards are now facing a significant examination. The next important date is February 26, 2027, when the FDA’s public comment period closes. What follows could shape the nutritional requirements governing infant formula across America for years to come.